It also addresses the FDA’s communications Using the applicant, the retention of information that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of the SE report back to a fresh applicant and electronic submission of your SE report an